Pfizer Inc. 2023-02-01 Health critical FDA
Health · FDA · Recall #FDA-D-0184-2023
Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose… Recall
Issued February 1, 2023 · Pfizer Inc.
In February 2023, Pfizer Inc. recalled the Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose…, a critical health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Presence of Particulate Matter: Glass particulate matter detected in injectable.
What you should do
- 1 Stop using Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Pfizer Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Pfizer Inc.
- Category
- Health
- Recall date
- February 1, 2023
- Units affected
- Not reported
- Sold at
- USA nationwide and Puerto Rico
- Recall number
- FDA-D-0184-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Pfizer Inc. has 13 recalls in our database, including 5 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.